Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FBTAX vs RYOIX overlap: 47% of top holdings shared

Bottom line

How much do FBTAX and RYOIX overlap?

47% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 42.6% of FBTAX's assets and 36.5% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

FBTAXRYOIX
Weight overlap (top 25)47%
Shared holdings11
Weight in shared holdings42.6%36.5%
Total positions12974
Expense ratio0.94%1.38%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings FBTAX and RYOIX have in common

Holding% of FBTAX% of RYOIXOverlap
Abbvie Inc14.71%8.17%8.17%
Gilead Sciences Inc5.70%4.49%4.49%
Alnylam Pharmaceuticals Inc3.62%2.36%2.36%
Insmed Inc3.05%1.79%1.79%
Revolution Medicines Inc3.00%2.48%2.48%
Argenx Se3.00%1.48%1.48%
Biogen Inc2.71%2.13%2.13%
Amgen Inc2.37%5.05%2.37%
Moderna Inc1.60%2.15%1.60%
Natera Inc1.43%2.12%1.43%
Vertex Pharmaceuticals Inc1.39%4.32%1.39%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FBTAX

  1. Spyre Therapeutics Inc — 3.83%
  2. Dianthus Therapeutics Inc — 3.55%
  3. Cogent Biosciences Inc — 3.25%
  4. Oruka Therapeutics Inc — 3.24%
  5. Ascendis Pharma A/s — 2.99%
  6. Mbx Biosciences Inc — 2.45%
  7. Amylyx Pharmaceuticals Inc — 2.25%
  8. Vaxcyte Inc — 1.97%
  9. Fidelity Revere Street Trust — 1.96%
  10. Relay Therapeutics Inc — 1.58%
  11. Viridian Therapeutics Inc — 1.53%
  12. Kiniksa Pharmaceuticals International Plc — 1.41%
  13. Enliven Therapeutics Inc — 1.25%
  14. Alumis Inc — 1.22%

Only in RYOIX

  1. Regeneron Pharmaceuticals Inc — 2.93%
  2. Beone Medicines Ltd — 2.17%
  3. Royalty Pharma Plc — 2.01%
  4. Illumina Inc — 1.94%
  5. United Therapeutics Corp — 1.72%
  6. Guardant Health Inc — 1.72%
  7. Roivant Sciences Ltd — 1.66%
  8. Incyte Corp — 1.62%
  9. Viatris Inc — 1.55%
  10. Neurocrine Biosciences Inc — 1.52%
  11. Jazz Pharmaceuticals Plc — 1.42%
  12. Bridgebio Pharma Inc — 1.38%
  13. Ionis Pharmaceuticals Inc — 1.35%
  14. Cytokinetics Inc — 1.35%

Asset mix

Asset typeFBTAXRYOIX
Stocks98.2%99.6%
Cash & short-term funds2.4%0.6%
Preferred stock1.5%—
Repurchase agreements—0.6%
Bonds0.1%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryFBTAXRYOIX
US87.8%85.8%
NL4.3%1.5%
CH—3.3%
GB1.8%3.2%
DK3.0%0.9%
IE—2.7%
KY1.8%0.5%
BM1.2%1.7%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do FBTAX and RYOIX overlap?
About 47% by weight. 11 securities appear in both funds' top 25 holdings; they make up 42.6% of FBTAX's assets and 36.5% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FBTAX and RYOIX have in common?
The largest shared holdings are Abbvie Inc, Gilead Sciences Inc, Revolution Medicines Inc, Amgen Inc, Alnylam Pharmaceuticals Inc.
Should I own both FBTAX and RYOIX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FBTAX or RYOIX?
FBTAX is broader, with 129 positions versus 74 for RYOIX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.